Document is current
Any future updates will be listed below
-
Authors
Shirani, Afsaneh https://orcid.org/0000-0002-8866-6426
Cross, Anne
- License Information
-
More Information
Article History
Received: 18 November 2025
Accepted: 18 December 2025
First Online: 10 January 2026
Declarations
:
: Ethical Consent not applicable for this study as it is a letter to editor.
: A. Shirani is a section editor for the Multiple Sclerosis section of Current Treatment Options in Neurology. She also serves on the editorial board of the Journal of Central Nervous System Disease, and Brain Sciences, and is an associate editor for Frontiers in Neurology and Frontiers in Immunology. She has received an honorarium for serving on the advisory medical board for TG therapeutics. A. Cross has received consulting fees within the past 3 years from Biogen, Bristol Myers Squibb, EMD-Serono, Genentech, Horizon, Novartis, F. Hoffman-La Roche, Sanofi, and TG Therapeutics. She has also conducted contracted research for Moderna.
